Market Overview: Gastric Cancer   27-slide PPT PowerPoint presentation slide deck (PPTX)
$299.00

Market Overview: Gastric Cancer (27-slide PPT PowerPoint presentation slide deck (PPTX)) Preview Image
Market Overview: Gastric Cancer (27-slide PPT PowerPoint presentation slide deck (PPTX)) Preview Image
Market Overview: Gastric Cancer (27-slide PPT PowerPoint presentation slide deck (PPTX)) Preview Image
Market Overview: Gastric Cancer (27-slide PPT PowerPoint presentation slide deck (PPTX)) Preview Image
Market Overview: Gastric Cancer (27-slide PPT PowerPoint presentation slide deck (PPTX)) Preview Image
Market Overview: Gastric Cancer (27-slide PPT PowerPoint presentation slide deck (PPTX)) Preview Image
Market Overview: Gastric Cancer (27-slide PPT PowerPoint presentation slide deck (PPTX)) Preview Image
Market Overview: Gastric Cancer (27-slide PPT PowerPoint presentation slide deck (PPTX)) Preview Image
Log in to unlock full preview.
Market Overview: Gastric Cancer (27-slide PPT PowerPoint presentation slide deck (PPTX)) Preview Image
Market Overview: Gastric Cancer (27-slide PPT PowerPoint presentation slide deck (PPTX)) Preview Image
Market Overview: Gastric Cancer (27-slide PPT PowerPoint presentation slide deck (PPTX)) Preview Image
Market Overview: Gastric Cancer (27-slide PPT PowerPoint presentation slide deck (PPTX)) Preview Image
Market Overview: Gastric Cancer (27-slide PPT PowerPoint presentation slide deck (PPTX)) Preview Image
Market Overview: Gastric Cancer (27-slide PPT PowerPoint presentation slide deck (PPTX)) Preview Image
Market Overview: Gastric Cancer (27-slide PPT PowerPoint presentation slide deck (PPTX)) Preview Image
Market Overview: Gastric Cancer (27-slide PPT PowerPoint presentation slide deck (PPTX)) Preview Image
Arrow   Click main image to view in full screen.

Market Overview: Gastric Cancer (PowerPoint PPTX Slide Deck)

PowerPoint (PPTX) 27 Slides

$299.00

Add to Cart
  


Immediate download
Fully editable PowerPoint
Free lifetime updates

BENEFITS OF THIS POWERPOINT DOCUMENT

  1. In 2015, major-market sales totaled $1.2 billion for gastric and gastroesophageal

HEALTHCARE PPT DESCRIPTION

This product (Market Overview: Gastric Cancer) is a 27-slide PPT PowerPoint presentation slide deck (PPTX), which you can download immediately upon purchase.

In 2015, major-market sales totaled $1.2 billion for gastric and gastroesophageal junction (GEJ) adenocarcinoma. We expect that major-market sales will rapidly increase over the forecast period, totaling almost $9.5 billion in 2025. This growth will be predominantly fuelled by the approval of seven agents in the indication, and also by Cyramza (Eli Lilly's ramucirumab).

The entry of three PD-1/PD-L1 inhibitors into the gastric and GEJ adenocarcinoma market (Merck & Co.'s Keytruda [pembrolizumab], Bristol Myers-Squibb/Ono Pharmaceutical's Opdivo [nivolumab], and Merck KGaA/Pfizer's avelumab) will significantly drive growth during the forecast period. We also forecast the approval of Yervoy (Bristol Myers-Squibb/Ono Pharmaceutical's ipilimumumab) to be used in conjunction with Opdivo. In addition, we anticipate the launch of a next generation HER2-targeting therapy (Roche/Genentech/Chugai's Perjeta [pertuzumab]), a cancer 'stemness' inhibitor (Boston Biomedical's napabucasin), and a MMP-9 inhibitor (Gilead Sciences's GS-5745). Collectively, these agents will contribute 80% of total sales in the gastric and GEJ adenocarcinoma in 2025.


Introduction
Key Findings
Market Share of Gastric Cancer Drug Classes in 2015 and 2025
Market SWOT Analysis
Etiology and Pathophysiology
Key Findings
Expert Insight
Pathophysiology
Anatomy
Subtypes
Staging and Classification
Key Pathways and Drug Targets
Market Outlook
Key Findings
Expert Insight
Market Overview
Market Drivers and Constraints
What Factors Are Driving the Market?
What Factors Are Constraining the Market?

Got a question about the product? Email us at support@flevy.com or ask the author directly by using the "Ask the Author a Question" form. If you cannot view the preview above this document description, go here to view the large preview instead.

Source: Best Practices in Healthcare, Cancer PowerPoint Slides: Market Overview: Gastric Cancer PowerPoint (PPTX) Presentation Slide Deck, pharmzolgas


$299.00

Add to Cart
  

ABOUT THE AUTHOR

Author: pharmzolgas
Additional documents from author: 3

Ask the Author a Question

You must be logged in to contact the author.

Click here to log in Click here register

Did you know?
The average daily rate of a McKinsey consultant is $6,625 (not including expenses). The average price of a Flevy document is $65.




Trusted by over 10,000+ Client Organizations
Since 2012, we have provided best practices to over 10,000 businesses and organizations of all sizes, from startups and small businesses to the Fortune 100, in over 130 countries.
AT&T GE Cisco Intel IBM Coke Dell Toyota HP Nike Samsung Microsoft Astrazeneca JP Morgan KPMG Walgreens Walmart 3M Kaiser Oracle SAP Google E&Y Volvo Bosch Merck Fedex Shell Amgen Eli Lilly Roche AIG Abbott Amazon PwC T-Mobile Broadcom Bayer Pearson Titleist ConEd Pfizer NTT Data Schwab




Read Customer Testimonials

 
"As a small business owner, the resource material available from FlevyPro has proven to be invaluable. The ability to search for material on demand based our project events and client requirements was great for me and proved very beneficial to my clients. Importantly, being able to easily edit and tailor "

– Michael Duff, Managing Director at Change Strategy (UK)
 
"I have used Flevy services for a number of years and have never, ever been disappointed. As a matter of fact, David and his team continue, time after time, to impress me with their willingness to assist and in the real sense of the word. I have concluded in fact "

– Roberto Pelliccia, Senior Executive in International Hospitality
 
"As a consultant requiring up to date and professional material that will be of value and use to my clients, I find Flevy a very reliable resource.

The variety and quality of material available through Flevy offers a very useful and commanding source for information. Using Flevy saves me time, enhances my expertise and ends up being a good decision."

– Dennis Gershowitz, Principal at DG Associates
 
"As a consulting firm, we had been creating subject matter training materials for our people and found the excellent materials on Flevy, which saved us 100's of hours of re-creating what already exists on the Flevy materials we purchased."

– Michael Evans, Managing Director at Newport LLC
 
"Flevy.com has proven to be an invaluable resource library to our Independent Management Consultancy, supporting and enabling us to better serve our enterprise clients.

The value derived from our [FlevyPro] subscription in terms of the business it has helped to gain far exceeds the investment made, making a subscription a no-brainer for any growing consultancy – or in-house strategy team."

– Dean Carlton, Chief Transformation Officer, Global Village Transformations Pty Ltd.
 
"Flevy is now a part of my business routine. I visit Flevy at least 3 times each month.

Flevy has become my preferred learning source, because what it provides is practical, current, and useful in this era where the business world is being rewritten.

In today's environment where there are so "

– Omar HernĂ¡n Montes Parra, CEO at Quantum SFE
 
"As a niche strategic consulting firm, Flevy and FlevyPro frameworks and documents are an on-going reference to help us structure our findings and recommendations to our clients as well as improve their clarity, strength, and visual power. For us, it is an invaluable resource to increase our impact and value."

– David Coloma, Consulting Area Manager at Cynertia Consulting
 
"Flevy is our 'go to' resource for management material, at an affordable cost. The Flevy library is comprehensive and the content deep, and typically provides a great foundation for us to further develop and tailor our own service offer."

– Chris McCann, Founder at Resilient.World


Your Recently Viewed Documents


Customers Also Like These Documents

Related Management Topics


Healthcare Cancer Value Chain Analysis Integrated Financial Model

Download our FREE Strategy & Transformation Framework Templates

Download our free compilation of 50+ Strategy & Transformation slides and templates. Frameworks include McKinsey 7-S, Balanced Scorecard, Disruptive Innovation, BCG Curve, and many more.